Management of Epstein-Barr virus reactiv
✍
Arjan C. Lankester
📂
Article
📅
2007
🏛
Wielkopolskie Centrum Onkologii
🌐
Polish
⚖ 64 KB
## Background Epstein-Barr virus (EBV) reactivation is a frequent event (5-20%) following allogeneic stem cell transplantation (allo-SCT) that may progress to life-threatening EBV-lymphoproliferative disease (EBV-LPD). ## Aim To present data relevant to incidence, diagnosis and contemporary man